The 20 Best ALK-Positive Non-Small Cell Lung Cancer Doctors Near Me in San Francisco, CA

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Quock is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Quock is currently accepting new patients.

Brian Haas is a Radiologist practicing medicine in San Francisco, California. He has been practicing medicine for over 17 years. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Nodules, Pleurisy, and Pleural Effusion.

Jin Yoo is a Radiologist practicing medicine in San Francisco, California. Dr. Yoo is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, ALK-Positive Non-Small Cell Lung Cancer, and Fibrolamellar Carcinoma.

Caring, compassionate, and patient centric care. Dr. Meyer is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Meyer is board certified in Radiology Diagnostic Radiology. Dr. Meyer is currently accepting new patients.

Peter Anastassiou is a Thoracic Surgeon practicing medicine in San Francisco, California. Dr. Anastassiou is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Esophageal Perforation, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Advanced Bronchoscopy. Dr. Anastassiou is board certified in Thoracic And Cardiac Surgery. Dr. Anastassiou is currently accepting new patients.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma. Dr. Gubens is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gubens is currently accepting new patients.

Dr. Yaron B. Gesthalter is a pulmonologist who treats patients with conditions affecting the airways, lungs and pleura (the membranes covering the lungs). These conditions include lung nodules, cancer, chronic obstructive pulmonary disease, pleural effusion, asthma, airway obstruction and interstitial lung disease. Gesthalter has a special interest in using minimally invasive procedures to treat cancers affecting the lungs. Gesthalter's research investigates how to reduce lung cancer risk through computational biological methods and lung cancer screening. Gesthalter earned his medical degree at Tel Aviv University and completed a residency in internal medicine at Yale University. At Boston University School of Medicine, he completed a fellowship in pulmonary and critical care medicine and a research fellowship in computational biomedicine. He then completed a fellowship in interventional pulmonary medicine at Beth Israel Deaconess Medical Center and Massachusetts General Hospital. Gesthalter is a member of the American Thoracic Society, International Society of Pleural Diseases and American Association for Bronchology and Interventional Pulmonology. Dr. Gesthalter is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Small Cell Lung Cancer (SCLC), Pleurisy, Endoscopy, and Advanced Bronchoscopy. Dr. Gesthalter is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Gesthalter is currently accepting new patients.

Alan Kramer is an Oncologist practicing medicine in San Francisco, California. Dr. Kramer is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Kramer is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Kramer is currently accepting new patients.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 1, and Small Bowel Resection. Dr. Sun is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Sun is currently accepting new patients.

Dr. Robert Flavell is a radiologist who cares for both adults and children, and specializes in nuclear medicine, the use of small amounts of radioactive materials to evaluate organ systems. He is chief of molecular imaging and therapeutics for the UCSF Department of Radiology and Biomedical Imaging. In research, Flavell focuses on developing new methods of diagnosing and treating cancer using molecular imaging technology, which shows what is taking place in the body at a cellular and molecular level. After earning a doctorate in chemical biology at the Rockefeller University, Flavell earned his medical degree at Weill Cornell Medicine. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in nuclear medicine. Dr. Flavell is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Smoldering Multiple Myeloma, Fibrolamellar Carcinoma, and Gastrointestinal Stromal Tumor. Dr. Flavell is board certified in American Board Of Radiology, Diagnostic Radiology and American Board Of Nuclear Medicine, Nuclear Medicine. Dr. Flavell is currently accepting new patients.

Dr. Spencer Behr is a radiologist with expertise in molecular imaging, radiation therapy and abdominal imaging. He has a special interest in radiomics, extracting data from medical images that can be used to better predict and assess a patient's response to cancer treatment. Behr pursues translational research – applying laboratory findings to the development of medical therapies – on the use of molecular and hybrid imaging to better treat prostate cancer. He is particularly interested in new radiology techniques that combine PET scanning with CT or MRI. He has pursued research projects that involve collaboration among multiple departments, aiming to foster discussions among specialists of various disciplines and to optimize the impact of these studies on patient care. Behr earned his medical degree from Tufts University School of Medicine. He completed a residency in diagnostic radiology at Lahey Hospital & Medical Center, serving as chief resident. At UCSF, he completed fellowships in abdominal imaging and nuclear medicine. Behr enjoys mentoring medical students, residents and fellows, and has received national recognition for his excellence in teaching and mentoring. He serves as fellowship director for radiology and biomedical imaging, co-director of the Helen Diller Family Comprehensive Cancer Center's Cancer Imaging Research Shared Resource and vice chair of UCSF's Committee on Rules & Jurisdiction. Dr. Behr is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Ureterocele, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Prostatectomy. Dr. Behr is board certified in American Board Of Nuclear Medicine, Nuclear Medicine and American Board Of Radiology, Diagnostic Radiology.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Blakely is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Blakely is currently accepting new patients.

Dr. Inga Lennes is a medical oncologist who cares for patients with lung cancer. She specializes in managing lung conditions, such as pulmonary nodules, and is an expert in lung screening. After earning her medical degree at the University of Massachusetts Chan Medical School, Lennes completed a residency in internal medicine at Beth Israel Deaconess Medical Center, where she served as chief resident. She completed a fellowship in hematology-oncology at Dana-Farber Brigham Cancer Center. She also has a master of public health degree from the Harvard T.H. Chan School of Public Health and a master of business administration degree from the Massachusetts Institute of Technology. She serves as president of the UCSF Faculty Practice Organization and senior vice president of ambulatory services at UCSF. Dr. Lennes is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, EGFR Positive Lung Cancer, Lung Nodules, and Non-Small Cell Lung Cancer (NSCLC). Dr. Lennes is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Lennes is currently accepting new patients.

Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the chest, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the genetic profile of the patient's cancer to custom-tailor treatment). Cheng leads research centered on developing innovative, next-generation treatments for lung cancer, including therapeutic clinical trials with new targeted therapies and immunotherapies. He is inspired by how research discoveries can lead to tangible benefits for patients. Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School. Cheng is a member of the American Society of Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation, as well as research funding from the National Institutes of Health and National Cancer Institute. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Cheng is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Cheng is currently accepting new patients.

Connie Li is a nurse practitioner who cares for patients with gastrointestinal cancers and has particular experience in treating neuroendocrine tumors. Li helps patients navigate life after a cancer diagnosis in ways that maximize their quality of life. She has a special interest in clinical trials, which assess promising new treatments, and survivorship, which focuses on continued care after completing cancer therapy. Li earned a bachelor's degree in human nutrition as well as her master's degree in nursing at the Ohio State University. Ms. Li is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer. Ms. Li is board certified in American Academy Of Nurse Practitioners, Family Nurse Practitioner. Ms. Li is currently accepting new patients.

Dr. Benjamin M. Yeh is a radiologist who specializes in abdominal imaging. He has particular expertise in computed tomography (CT), contrast materials (substances introduced to make certain internal structures more visible), advanced liver imaging, and imaging of the genital and urinary organs. Yeh has received grants from the National Institutes of Health to study and develop novel CT contrast materials. He holds three patents. Yeh earned his medical degree at Duke University. He completed a residency in radiology and a fellowship in abdominal imaging at UCSF. Yeh is active in teaching at UCSF. Dr. Yeh is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, WT1-Related Wilms Tumor Syndromes, Small Bowel Resection, and Liver Embolization. Dr. Yeh is board certified in American Board Of Radiology, Diagnostic Radiology.

Dr. Brett M. Elicker is a specialist in thoracic radiology. He has a particular interest in evaluating interstitial lung disease with the advanced imaging techniques of high-resolution computed tomography. Elicker earned his medical degree at New York Medical College. He completed a residency in diagnostic radiology at Yale University and a fellowship in thoracic imaging at UCSF. Dr. Elicker is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Pulmonary Fibrosis, Lung Nodules, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Elicker is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Elicker is currently accepting new patients.

Dr. Zhen Jane Wang is a radiologist who specializes in abdominal imaging. In research, Wang's interests focus on identifying novel imaging techniques and developing them into practical, useful diagnostic tools. Her research program includes using hyperpolarized 13C metabolic MRI – an advanced imaging technique – to assess kidney tumors' aggressiveness and diffuse kidney disease. She is also interested in quantitative imaging – a technique for measuring features of a tumor by applying algorithms to images – for assessing patients with pancreatic cancer. Wang has received research grants from private and public organizations, including the Society of Abdominal Radiology, Radiological Society of North America, U.S. Department of Defense and National Institutes of Health. In 2019, she received the Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research. After earning a bachelor's degree in electrical engineering at Brown University, Wang earned her medical degree from Northwestern University Feinberg School of Medicine. She completed a residency in diagnostic radiology at UCSF, serving as chief resident. She also completed a fellowship in abdominal imaging at UCSF. She joined the UCSF faculty in 2008. Wang serves as associate director for UCSF's program in biomedical imaging for clinician-scientists and as associate chair for strategic planning in the UCSF Department of Radiology and Biomedical Imaging. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Spontaneous Coronary Artery Dissection (SCAD), Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Percutaneous Coronary Intervention (PCI). Dr. Wang is board certified in American Board Of Radiology/Diagnostic Radiology, Diagnostic Radiology. Dr. Wang is currently accepting new patients.

Donald Abrams is an Oncologist practicing medicine in San Francisco, California. Dr. Abrams is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.